Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Government to develop...

    Government to develop six bulk drugs, medical devices parks

    Written by savita thakur thakur Published On 2016-06-09T11:50:37+05:30  |  Updated On 9 Jun 2016 11:50 AM IST
    Government to develop six bulk drugs, medical devices parks

    NEW DELHI: To reduce import dependence, the government has decided to establish six bulk drug and medical devices parks, which will entail a combined investment of Rs 60,000 crore.


    "The government has decided to establish 3 bulk drugs and 3 medical devices parks across the country. These parks will require an investment of about Rs 60,000 crore," Fertiliser Minister Ananth Kumar told PTI.


    As per various estimates, once these parks become operational, they can bring down the cost of production of devices and bulk drugs by at least 30 per cent and in long-run, this will help the general public also, he said.


    "As much as 80 per cent of our total requirement of bulk drugs/APIs and 65 per cent of total demand of medical devices is met through imports. So, we want this to be reduced by facilitating domestic manufacturing," Kumar said.


    These parks will be established on the public private partnership (PPP) mode and the centre is in talks with various states for setting up of these parks, he said.


    "We are also considering to provide one-time financial support for these bulk drug parks," he added.


    These bulk drug and medical devices parks will have common facilities like testing, power and effluent treatment plants.


    Besides, there will be common utilities and services such as storage, testing laboratories, IPR management, designing and guest house/accommodation, maintained by a separate special purpose vehicle.


    The Minister also informed that Department of Pharmaceuticals has moved an updated cabinet note on policy for bulk drugs which is under circulation.


    The department has taken into considerations all recommendations of V M Katoch committee, which was constituted in 2013, to study the whole issue of active pharmaceutical ingredients (APIs) of critical importance.


    Bulk drugs are used as raw materials by the pharmaceuticals industry.

    3 bulk drugs3 medical devicesactive pharmaceutical ingredientsAPIsDepartment of PharmaceuticalsFertiliser Minister Ananth KumarIPR managementmedical devices parksPPPpublic private partnershiptesting laboratoriesV M Katoch committee
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok